🇺🇸 FDA
Pipeline program

Tranexamic Acid

NTA1702

Phase 2 small_molecule completed

Quick answer

Tranexamic Acid for Intracerebral Haemorrhage is a Phase 2 program (small_molecule) at Neuroscience Trials Australia with 1 ClinicalTrials.gov record(s).

Program details

Company
Neuroscience Trials Australia
Indication
Intracerebral Haemorrhage
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials